Validation CSV Expert GDIT R&D and Medical
Ipsen Global
Validation CSV Expert GDIT R&D and Medical
Ipsen Global
Global biopharma focused on specialty care
Title:
Validation CSV Expert GDIT R&D and MedicalCompany:
Ipsen Pharma (SAS)About Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.
Job Description:
Ipsen is strengthening its R&D and Medical Digital & IT organization to ensure the highest standards of compliance, quality, and audit readiness across its digital ecosystem.
We are looking for a Computer System Validation (CSV) Manager to act as the quality gatekeeper for IT systems supporting R&D activities. In this role, you will ensure that all computerized systems are fully compliant with regulatory requirements and internal quality standards, while enabling innovation and efficient delivery of digital solutions.
You will work at the intersection of IT, Quality, Regulatory, and business teams, ensuring that systems are validated, audit-ready, and aligned with global compliance frameworks.
Global biopharma focused on specialty care
Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.
Explore more opportunities at Ipsen Global